Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Cytodyn Inc
(OP:
CYDY
)
0.3498
+0.0039 (+1.13%)
Streaming Delayed Price
Updated: 12:14 PM EDT, May 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Cytodyn Inc
< Previous
1
2
3
4
5
Next >
Leronlimab (350 mg) Weekly Use for 14 Weeks in Open Label Arm of NASH Trial Produces Fibrosis Reduction as High as 93 msec Amongst First 15 Patients with Average Reduction of 24 msec
November 24, 2021
From
CytoDyn Inc.
Via
Business Wire
CytoDyn Research Paper on Leronlimab Published in Frontiers in Immunology Journal
November 19, 2021
From
CytoDyn Inc.
Via
Business Wire
Health Canada Authorizes Emergency Use of Leronlimab for Treatment of First Triple-Negative Breast Cancer Patient in Canada
November 16, 2021
From
CytoDyn Inc.
Via
Business Wire
CytoDyn Inc. Announces Adjournment of Annual Meeting of Shareholders to November 24, 2021 Due to Lack of Quorum
October 28, 2021
From
CytoDyn Inc.
Via
Business Wire
CytoDyn Announces Delaware Court Has Denied Activist Group’s Motion to Prevent Annual Meeting from Taking Place
October 20, 2021
From
CytoDyn Inc.
Via
Business Wire
CytoDyn Alerts Shareholders to Vote on Company’s Proxy Card Ahead of October 28th Annual Meeting
October 18, 2021
From
CytoDyn Inc.
Via
Business Wire
Group of CytoDyn Stockholders Comments on Delaware Court Decision
October 14, 2021
From
Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via
Business Wire
Delaware Court Agrees with CytoDyn that Activist Group’s Nominations are Invalid
October 14, 2021
From
CytoDyn Inc.
Via
Business Wire
These OTC Markets Securities had the Most Trading Activity in September
↗
October 12, 2021
Photo by Annie Spratt on Unsplash As the 3rd quarter came to a close in September, the OTC Markets saw a slight decrease in total trading volume even as companies reported...
Via
Benzinga
CytoDyn Comments on Rosenbaum/Patterson Activist Group “Plan”
September 29, 2021
From
CytoDyn Inc.
Via
Business Wire
Group of CytoDyn Stockholders Releases White Paper Regarding Company’s Extremely Unfavorable Borrowing Practices
September 27, 2021
From
Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via
Business Wire
CytoDyn to Present at Emerging Growth Conference on September 29 Followed by Live Q/A
September 27, 2021
From
CytoDyn Inc.
Via
Business Wire
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
↗
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
Group of CytoDyn Stockholders Shares Strategic Plan to Obtain Cancer Therapy Approval for Leronlimab
September 24, 2021
From
Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via
Business Wire
Accelerated Development of COVID-19 Vaccines to Combat Potential for Possible Future Viral Pathogens and Variants
September 22, 2021
Via
FinancialNewsMedia
CytoDyn Receives Clearance from Brazil’s FDA (ANVISA) to Commence a Pivotal Phase 3 Trial in Critically Ill COVID-19 Patients with IV Administration of Four Doses (700mg/week)
September 22, 2021
From
CytoDyn Inc.
Via
Business Wire
CytoDyn’s Chairman, CMO, and Head of Business Development Dr. Scott A. Kelly to Present at the World Antiviral Congress 2021
September 21, 2021
From
CytoDyn Inc.
Via
Business Wire
Group of CytoDyn Stockholders Announces Federal Court Dismisses Litigation Brought by Company
September 20, 2021
From
Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via
Business Wire
CytoDyn Announces Resolution of Federal Litigation with Rosenbaum/Patterson Activist Group
September 20, 2021
From
CytoDyn Inc.
Via
Business Wire
Bruce Patterson, M.D., Director Candidate for CytoDyn Board, Presents at International COVID Summit
September 17, 2021
From
Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via
Business Wire
Glancy Prongay & Murray LLP Announces Investigation of CytoDyn Inc.
September 15, 2021
From
Glancy Prongay & Murray LLP
Via
Business Wire
Group of CytoDyn Stockolders Responds to Misleading Company News Release
September 07, 2021
From
Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via
Business Wire
CytoDyn Highlights Court Ordering Rosenbaum/Patterson Group to Comply With the Federal Securities Laws
September 02, 2021
From
CytoDyn Inc.
Via
Business Wire
Why Experts Believe Antibody Treatments Hold The Potential To Reduce Need For Hospitalization For COVID-19 Patients
September 14, 2021
Via
FinancialNewsMedia
Group of CytoDyn Stockholders Warns Stockholders of Board’s Continued Value Destruction and Failures
September 02, 2021
From
Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via
Business Wire
The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
↗
September 10, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...
Via
Benzinga
Group of CytoDyn Stockholders Files Lawsuit to Force Company to Allow Stockholders to Vote for Alternative Director Nominees
August 26, 2021
From
Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via
Business Wire
CytoDyn Urges Shareholders to Ignore Proxy Cards from Rosenbaum/Patterson Group
August 25, 2021
From
CytoDyn
Via
Business Wire
Group of CytoDyn Stockholders Responds to Highly Misleading Company Release
August 19, 2021
From
Gasthalter & Co. on behalf of CytoDyn Inc. shareholders
Via
Business Wire
CytoDyn Provides Update on Rosenbaum/Patterson Group Litigation
August 19, 2021
From
CytoDyn Inc.
Via
Business Wire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
